Current Pharmaceutical Design,
Journal Year:
2022,
Volume and Issue:
28(22), P. 1780 - 1797
Published: May 22, 2022
Coronavirus
disease
2019
(COVID-19)
continues
to
spread
globally
despite
the
discovery
of
vaccines.
Many
people
die
due
COVID-19
as
a
result
catastrophic
consequences,
such
acute
respiratory
distress
syndrome,
pulmonary
embolism,
and
disseminated
intravascular
coagulation
caused
by
cytokine
storm.
Immunopathology
immunogenetic
research
may
assist
in
diagnosing,
predicting,
treating
severe
storm
associated
with
COVID-19.
This
paper
reviews
immunopathogenesis
variants
that
play
role
Although
various
immune-related
genetic
have
been
investigated
relation
COVID-19,
NOD-like
receptor
protein
3
(NLRP3)
interleukin
18
(IL-18)
not
assessed
for
their
potential
significance
clinical
outcome.
Here,
we
a)
summarize
current
understanding
etiology
pathophysiology
storm;
b)
construct
analyze
protein-protein
interaction
(PPI)
networks
(using
enrichment
annotation
analysis)
based
on
NLRP3
IL18
all
genes,
which
were
established
Our
PPI
network
analyses
predict
useful
drug
targets
prevent
onset
including
key
antiviral
pathways
Toll-Like-Receptor
cascades,
signaling,
RIG-induction
interferon
(IFN)
α/β,
(IL)-1,
IL-6,
IL-12,
IL-18,
tumor
necrosis
factor
signaling;
SARS-CoV-2
innate
immune
evasion
participation
MYD88
MAVS
The
be
used
more
outcomes,
thereby
opening
door
targeted
preventive
treatments.
Viruses,
Journal Year:
2022,
Volume and Issue:
14(12), P. 2797 - 2797
Published: Dec. 15, 2022
In
the
current
global
scenario,
many
COVID-19
survivors
present
a
severe
deterioration
in
physical
strength,
respiratory
function,
and
quality
of
life
due
to
persistent
symptoms
post-acute
consequences
SARS-CoV-2
infection.
These
alterations
are
known
as
post-COVID-19
syndrome
for
which
there
is
no
specific
effective
treatment
their
management.
Currently,
therapeutic
exercise
strategies
(ThEx)
diseases
by
reducing
appearance
complications
side
effects
linked
treatment,
consequently
great
relevance.
this
study,
we
review
effect
ThEX
reversing
decreased
impaired
fitness,
(QoL)
caused
syndrome.
A
literature
search
was
conducted
through
electronic
databases,
Medline
(PubMed),
SciELO
Cochrane
Library
Plus
structured
narrative
studies
published
from
database
retrieval
up
till
12
December
2022.
total
433
patients
with
condition
(60%
women)
were
included
nine
met
inclusion/exclusion
criteria.
Overall,
who
followed
ThEx
intervention
showed
improvements
fitness
QoL,
exercise-derived
effects.
Thus,
based
on
aerobic
training
could
be
an
adjuvant
non-pharmacological
tool
modulation
Frontiers in Cellular and Infection Microbiology,
Journal Year:
2022,
Volume and Issue:
12
Published: June 14, 2022
The
severe
acute
respiratory
coronavirus
2
(SARS-CoV-2)
has
become
a
life-threatening
pandemic.
Clinical
evidence
suggests
that
kidney
involvement
is
common
and
might
lead
to
mild
proteinuria
even
advanced
injury
(AKI).
Moreover,
AKI
caused
by
disease
2019
(COVID-19)
been
reported
in
several
countries
regions,
resulting
high
patient
mortality.
COVID-19‐induced
affected
factors
including
direct
mediated
the
combination
of
virus
angiotensin-converting
enzyme
2,
immune
response
dysregulation,
cytokine
storm
driven
SARS-CoV-2
infection,
organ
interactions,
hypercoagulable
state,
endothelial
dysfunction.
In
this
review,
we
summarized
mechanism
infection
through
literature
search
analysis.
Frontiers in Immunology,
Journal Year:
2022,
Volume and Issue:
12
Published: Jan. 13, 2022
Collapsing
glomerulopathy
represents
a
special
variant
of
the
proteinuric
kidney
disease
focal
segmental
glomerulosclerosis
(FSGS).
Histologically,
collapsing
form
FSGS
(cFSGS)
is
characterized
by
or
global
condensation
and
obliteration
glomerular
capillaries,
appearance
hyperplastic
hypertrophic
podocytes
severe
tubulointerstitial
damage.
Clinically,
cFSGS
patients
present
with
acute
injury,
nephrotic-range
proteinuria
are
at
high
risk
rapid
progression
to
irreversible
failure.
can
be
attributed
numerous
etiologies,
namely,
viral
infections
like
HIV,
cytomegalovirus,
Epstein–Barr-Virus,
parvovirus
B19
also
drugs
ischemia.
Risk
variants
APOL1
gene,
predominantly
found
in
people
African
descent,
increase
developing
cFSGS.
Patients
infected
new
Corona-Virus
SARS-CoV-2
display
an
increased
rate
injury
(AKI)
cases
COVID-19.
Besides
hemodynamic
instability,
cytokine
mediated
direct
entry
infection
renal
epithelial
cells
contributing
AKI,
there
emerging
reports
associated
mainly
ethnicity.
The
pathogenesis
proposed
linked
podocytes,
as
described
for
HIV-associated
glomerulopathy.
Nevertheless,
growing
evidence
that
systemic
inflammatory
cascade,
activated
COVID-19,
major
contributor
impairment
basic
cellular
functions
podocytes.
This
mini
review
will
summarize
current
knowledge
on
focus
influence
immune
responses
potential
mechanisms
propagating
development
International Journal of Molecular Sciences,
Journal Year:
2022,
Volume and Issue:
23(8), P. 4167 - 4167
Published: April 9, 2022
Theophylline
(3-methyxanthine)
is
a
historically
prominent
drug
used
to
treat
respiratory
diseases,
alone
or
in
combination
with
other
drugs.
The
rapid
onset
of
the
COVID-19
pandemic
urged
development
effective
pharmacological
treatments
directly
attack
new
variants
SARS-CoV-2
virus
and
possess
therapeutical
battery
compounds
that
could
improve
current
management
disease
worldwide.
In
this
context,
theophylline,
through
bronchodilatory,
immunomodulatory,
potentially
antiviral
mechanisms,
an
interesting
proposal
as
adjuvant
treatment
patients.
Nevertheless,
it
essential
understand
how
compound
behave
against
such
disease,
not
only
at
pharmacodynamic
but
also
pharmacokinetic
level.
sense,
quickest
approach
discovery
different
computational
methods,
either
from
network
pharmacology
quantitative
systems
approaches.
present
review,
we
explore
possibility
using
theophylline
patients
since
seems
be
relevant
candidate
by
aiming
several
immunological
targets
involved
pathophysiology
disease.
down-regulates
inflammatory
processes
activated
various
herein,
they
are
discussed
reviewing
simulation
studies
their
applications
effects.
Journal of Travel Medicine,
Journal Year:
2023,
Volume and Issue:
30(5)
Published: June 10, 2023
Abstract
Introduction
Evidence
on
long-term
associations
between
coronavirus
disease
2019
(COVID-19)
and
risks
of
multi-organ
complications
mortality
in
older
population
is
limited.
This
study
evaluates
these
associations.
Research
design
methods
The
cohorts
included
patients
aged
≥60
year
diagnosed
with
COVID-19
infection
(cases),
16
March
2020
31
May
2021
from
the
UK
Biobank;
01
April
2022
electronic
health
records
Hong
Kong.
Each
patient
was
randomly
matched
individuals
without
based
birth
sex
were
followed
for
up
to
18
months
until
August
UKB,
28
15
HK
cohort.
Patients
over
6
after
date
last
dose
vaccination
their
corresponding
controls
excluded
our
study.
Characteristics
further
adjusted
Inverse
Probability
Treatment
Weighting.
For
evaluating
association
21-days
diagnosis,
Cox
regression
employed.
Result
10,759
(UKB)
165,259
(HK)
adults
291,077
1,100,394
non-COVID-19-diagnosed
recruited.
Older
associated
a
significantly
higher
risk
cardiovascular
outcomes
[major
(stroke,
heart
failure
coronary
disease):
hazard
ratio(UKB):
1.4
(95%
Confidence
interval:
1.1,1.6),
HK:1.2
CI:
1.1,1.3)];
myocardial
infarction:
HR(UKB):
1.8
1.3,2.4),
1.0,1.4)];
respiratory
[interstitial
lung
disease:
HR(UKB:
3.4
2.5,4.5),
HK:
4.0
1.3,12.8);
chronic
pulmonary
1.7
1.3,2.2),
HK:1.6
1.3,2.1)];
neuropsychiatric
[seizure:
2.6
1.7,4.1),
1.6
1.2,2.1)];
renal
[acute
kidney
all-cause
[HR(UKB):
4.9
4.4,5.4),
HK:2.5
2.5,2.6)].
Conclusion
(aged
≥
60).
Infected
this
age-group
may
benefit
appropriate
monitoring
signs/symptoms
developing
complications.
Cells,
Journal Year:
2023,
Volume and Issue:
12(10), P. 1349 - 1349
Published: May 9, 2023
Coronavirus
disease
2019
(COVID-19)
is
a
viral
infection
caused
by
SARS-CoV-2
that
induces
generalized
inflammatory
state.
Organokines
(adipokines,
osteokines,
myokines,
hepatokines,
and
cardiokines)
can
produce
beneficial
or
harmful
effects
in
this
condition.
This
study
aimed
to
systematically
review
the
role
of
organokines
on
COVID-19.
PubMed,
Embase,
Google
Scholar,
Cochrane
databases
were
searched,
Preferred
Reporting
Items
for
Systematic
Reviews
Meta-Analyses
(PRISMA)
guidelines
followed,
37
studies
selected,
comprising
more
than
2700
individuals
infected
with
virus.
Among
COVID-19
patients,
have
been
associated
endothelial
dysfunction
multiple
organ
failure
due
augmented
cytokines
increased
viremia.
Changes
pattern
secretion
directly
indirectly
contribute
aggravating
infection,
promoting
immune
response
alterations,
predicting
progression.
These
molecules
potential
be
used
as
adjuvant
biomarkers
predict
severity
illness
severe
outcomes.
Biomedicines,
Journal Year:
2024,
Volume and Issue:
12(4), P. 913 - 913
Published: April 20, 2024
Background:
Post-acute
sequelae
of
SARS-CoV-2
infection
(PASC)
is
a
complicated
disease
that
affects
millions
people
all
over
the
world.
Previous
studies
have
shown
PASC
impacts
10%
infected
patients
which
50–70%
are
hospitalised.
It
has
also
been
10–12%
those
vaccinated
against
COVID-19
were
affected
by
and
its
complications.
The
severity
later
development
symptoms
positively
associated
with
early
intensity
infection.
Results:
generated
health
complications
caused
involve
vast
variety
organ
systems.
Patients
diagnosed
neuropsychiatric
neurological
symptoms.
cardiovascular
system
involved
several
diseases
such
as
myocarditis,
pericarditis,
coronary
artery
reported.
Chronic
hematological
problems
thrombotic
endothelialitis
hypercoagulability
described
conditions
could
increase
risk
clotting
disorders
coagulopathy
in
patients.
Chest
pain,
breathlessness,
cough
respiratory
long-COVID
causing
distress
syndrome.
observed
immune
notable,
involving
diseases.
renal
was
impacted,
resulted
raising
issues,
fibrosis,
sepsis.
Endocrine
gland
malfunction
can
lead
to
diabetes,
thyroiditis,
male
infertility.
Symptoms
diarrhea,
nausea,
loss
appetite,
taste
among
reported
observations
due
gastrointestinal
disorders.
Skin
abnormalities
might
be
an
indication
long-term
implications
persistent
cutaneous
complaints
linked
PASC.
Conclusions:
Long-COVID
multidimensional
syndrome
considerable
public
implications,
affecting
physiological
systems
demanding
thorough
medical
therapy,
more
study
address
underlying
causes
effects
needed.
International Journal of Molecular Sciences,
Journal Year:
2022,
Volume and Issue:
23(8), P. 4244 - 4244
Published: April 11, 2022
Sphingolipids,
which
act
as
a
bioactive
signaling
molecules,
are
involved
in
several
cellular
processes
such
cell
survival,
proliferation,
migration
and
apoptosis.
An
imbalance
the
levels
of
sphingolipids
can
be
lethal
to
cells.
Abnormalities
associated
with
human
diseases
including
kidney
diseases.
Several
studies
demonstrate
that
play
an
important
role
maintaining
proper
renal
function.
Sphingolipids
alter
glomerular
filtration
barrier
by
affecting
functioning
podocytes,
key
components
barrier.
This
review
summarizes
our
understanding
regulation
sphingolipid
diseases,
especially
tubulointerstitial
potential
target
pathways
developing
therapeutics
for
treatment
Diseases,
Journal Year:
2022,
Volume and Issue:
10(3), P. 53 - 53
Published: Aug. 19, 2022
Coronavirus
disease
2019
(COVID-19)
is
a
caused
by
infection
with
the
SARS-CoV-2
virus
and
has
represented
one
of
greatest
challenges
humanity
faced
in
recent
years.
The
can
infect
large
number
organs,
including
lungs
upper
respiratory
tract,
brain,
liver,
kidneys,
intestines,
among
many
others.
Although
damage
occurs
lungs,
kidneys
are
not
exempt,
acute
kidney
injury
(AKI)
occur
patients
COVID-19.
Indeed,
AKI
most
frequent
serious
organic
complications
incidence
COVID-19
varies
widely,
exact
mechanisms
how
damages
still
unknown.
For
this
reason,
purpose
review
was
to
assess
current
findings
on
pathogenesis,
clinical
features,
therapy,
mortality
AKI.
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(9), P. 8290 - 8290
Published: May 5, 2023
Severe
Acute
Respiratory
Syndrome
CoronaVirus
2
(SARS-CoV-2)
infection
triggers
various
events
from
molecular
to
tissue
level,
which
in
turn
is
given
by
the
intrinsic
characteristics
of
each
patient.
Given
diversity
characteristic
cellular
phenotype,
possible
cytopathic,
and
clinical
effects
are
difficult
predict,
determines
heterogeneity
COVID-19
symptoms.
The
purpose
this
article
provide
a
comprehensive
review
cytopathic
SARS-CoV-2
on
cell
types,
focusing
development
COVID-19,
may
lead,
some
patients,
persistence
symptoms
after
recovery
disease,
condition
known
as
long
COVID.
We
describe
mechanisms
underlying
virus-host
interactions,
including
alterations
protein
expression,
intracellular
signaling
pathways,
immune
responses.
In
particular,
highlights
potential
impact
these
cytopathies
function
outcomes,
such
dysregulation,
neuropsychiatric
disorders,
organ
damage.
concludes
discussing
future
directions
for
research
implications
management
treatment